Research and Markets has announced the addition of the "Cancer Vaccines: Technologies and Global Markets" report to their offering.
The global market for cancer vaccines was valued at nearly $4.2 billion and $4.0 billion in 2014 and 2015, respectively. This market is expected to decline from nearly $3.5 billion in 2016 to $3.4 billion in 2021 at a compound annual growth rate (CAGR) of -0.4% for 2016-2021.
The report covers the total market of cancer vaccines, which includes two main areas of applications, prophylactic vaccines and therapeutic vaccines. Human papillomavirus (HPV) vaccines and hepatitis B vaccines that indirectly act against cancer are also included in the report.
The report also covers the global market of cancer vaccines by application in various cancer types such as prostate, liver, cervical and others such as lung and urinary bladder. It is discussed from both a commercial perspective and that of a research and development (R&D) perspective.
This report provides:
Key Topics Covered:
2: Executive Summary
4: Regulatory Aspects
5: New Developments
6: Market Analysis
7: Industry Structure
8: Market By Application
9: Patent Analysis
10: Current Situation
11: Company Profile
For more information about this report visit http://www.researchandmarkets.com/research/q5djzw/cancer_vaccines
View source version on businesswire.com: http://www.businesswire.com/news/home/20161124005097/en/Business Wire
Last updated on: 24/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.